Skip to main content
Fig. 3 | BMC Pharmacology and Toxicology

Fig. 3

From: Immunomodulatory effects of detoxification agents on dendritic cell populations in methamphetamine addiction

Fig. 3

The percentage of dendritic cells, CD11c + dendritic cells, and CD123 + dendritic cells in the peripheral blood of Methamphetamine addicts during the detoxification period. The percentage of dendritic cells (A), CD11c + dendritic cells (B), and CD123 + dendritic cells (C) in the peripheral blood of Methamphetamine addicts during the detoxification period compared to control group. DC = Dendritic cell, RisMeth = Methamphetamine addicts treated with Risperidone, RisMpMeth = Methamphetamine addicts treated with Risperidone and Methylphenidate, a = beginning of the trial, b = End of detoxification, c = no more than one month after detoxification. Data is presented as mean ± standard deviation. The results are obtained from the analysis of 100,000 mononuclear cells. The signs *(†) **(††) and ***(†††) indicate P < 0.05, P < 0.005, and P < 0.0005, respectively. The * sign for comparisons to the control, and the † sign denotes group comparisons

Back to article page